1. Home
  2. KB vs TEVA Comparison

KB vs TEVA Comparison

Compare KB & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Financial Group Inc

KB

KB Financial Group Inc

HOLD

Current Price

$86.41

Market Cap

31.2B

Sector

Finance

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$28.66

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KB
TEVA
Founded
2008
1901
Country
South Korea
Israel
Employees
126
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KB
TEVA
Price
$86.41
$28.66
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$29.78
AVG Volume (30 Days)
134.3K
10.9M
Earning Date
02-06-2026
01-28-2026
Dividend Yield
2.34%
N/A
EPS Growth
31.42
N/A
EPS
10.70
0.62
Revenue
$10,599,662,483.00
$16,776,000,000.00
Revenue This Year
$17.52
$4.74
Revenue Next Year
$2.13
$0.48
P/E Ratio
$7.77
$45.91
Revenue Growth
5.94
0.02
52 Week Low
$46.38
$12.47
52 Week High
$92.39
$29.10

Technical Indicators

Market Signals
Indicator
KB
TEVA
Relative Strength Index (RSI) 52.75 80.42
Support Level $87.09 $28.00
Resistance Level $88.98 $26.96
Average True Range (ATR) 1.26 0.65
MACD 0.02 0.14
Stochastic Oscillator 56.24 89.59

Price Performance

Historical Comparison
KB
TEVA

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: